| Health alert on popular painkiller |
| News - Health | |||
| Friday, 03 July 2009 09:27 | |||
|
Use of New Zealand's most widely taken painkiller, paracetamol, is being reviewed because of concerns in the United States about side-effects that include liver damage. Three advisory committees have advised the US Food and Drug Administration to reduce the single maximum dose of the common painkiller - known in the US as acetaminophen - from 1000mg to 650mg. They also recommended reducing the maximum daily dose, but did not specify by how much. The FDA does not have to follow the advice of its panels, though it usually does. The agency has given no indication on when it might act on the recommendations. New Zealand's drug regulator, Medsafe, said yesterday that it was consulting the FDA to see if any action was needed here. Health experts the Herald spoke to welcomed the review. Medsafe group manager Dr Stewart Jessamine said the number of tablets in each packet and the strength of the drug were lower in New Zealand than in the United States. Local laws required product labels to identify medicines containing paracetamol and warn that other paracetamol medicines should not be taken at the same time.
Set as favorite
Email this
Comments (0)
![]() Write comment
You must be logged in to post a comment. Please register if you do not have an account yet.
|
You need to login or register to post comments.
Discuss this item on the forums. (0 posts)
